For the UChicago doctors and molecular engineers working to enlist our own immune systems in the battle against cancer, successes and setbacks alike are critical to making the next leap.
When telling the story of immunotherapy and cancer and how the two battle it out, it's awfully challenging not to pull out the old A Tale of Two Cities cliché. Because everyone agrees: It is the best of times in cancer research treatment.
Over the past five years, the standard of care for treatment of many cancers has made a decided shift toward marshalling a patient's own immune system to attack the disease. The full spectrum of immunotherapies available are administered at the University of Chicago Medicine Comprehensive Cancer Center.
UChicago graduates Thomas Gajewski, PhD'89, MD'91 and Thelma Tennant, PhD'03 are featured in the rest of the article on UChicago Magazine.